Laxmin Laxminarain
Net worth: - $ as of 31/10/2026
Net worth: - $ as of 31/10/2026
Prattipati Laxminarain is currently Director at Oculogica, Inc. since 2018, Director at Millar, Inc. since 2018, Independent Director at Microbot Medical, Inc. since 2017, Director at GT Medical Technologies, Inc. since 2019, and Operating Advisor at Revival Healthcare Capital LLC.
Former roles include Chief Executive Officer at Deinde Medical Corp.
and President & Director at Cerenovus, Inc. from 2006 to 2017.
Education includes an MBA from Indian Institute of Management Ahmedabad and an undergraduate degree from Osmania University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MICROBOT MEDICAL INC -.--% | 01/04/2026 | 0 ( -.--% ) | - $ | 31/10/2026 |
| Companies | Position | Start |
|---|---|---|
| MICROBOT MEDICAL INC. | Director/Board Member | 06/12/2017 |
Millar, Inc.
Millar, Inc. Medical SpecialtiesHealth Technology Develops pressure sensing technologies for medical devices | Director/Board Member | 05/12/2018 |
GT Medical Technologies, Inc.
GT Medical Technologies, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical equipment for the treatment of brain tumors | Director/Board Member | 31/01/2019 |
Oculogica, Inc.
Oculogica, Inc. Medical SpecialtiesHealth Technology Develops eye-tracking based neurodiagnostics to detect concussion and traumatic brain injury | Director/Board Member | 01/04/2018 |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital invests in companies located in the United States with an enterprise value of USD 150 - 1000 million and revenue of USD 10 - 500 million. The firm targets companies operating in the fields of pharmaceuticals, biotech, drug development and discovery & healthcare services. It provides financing for buyout, recapitalization and growth stage capital requirements with an investment size of USD 10 - 250 million. The firm acquires majority, minority and controlling interest and makes co-investments. It also acts as a lead investor. | Consultant / Advisor | - |
| Companies | Position | End |
|---|---|---|
Cerenovus, Inc.
Cerenovus, Inc. Medical SpecialtiesHealth Technology Develops and markets diagnostic and therapeutic products | President | 01/01/2017 |
Deinde Medical Corp.
Deinde Medical Corp. Medical/Nursing ServicesHealth Services Provides healthcare services | Chief Executive Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 9 |
|---|---|
Oculogica, Inc.
Oculogica, Inc. Medical SpecialtiesHealth Technology Develops eye-tracking based neurodiagnostics to detect concussion and traumatic brain injury | Health Technology |
Cerenovus, Inc.
Cerenovus, Inc. Medical SpecialtiesHealth Technology Develops and markets diagnostic and therapeutic products | Health Technology |
Indian Institute of Management Ahmedabad
Indian Institute of Management Ahmedabad Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Osmania University
Osmania University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Millar, Inc.
Millar, Inc. Medical SpecialtiesHealth Technology Develops pressure sensing technologies for medical devices | Health Technology |
Microbot Medical, Inc.
Microbot Medical, Inc. BiotechnologyHealth Technology Specializes in the research, design, development and commercialization of micro-robotics assisted medical technologies | Health Technology |
GT Medical Technologies, Inc.
GT Medical Technologies, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical equipment for the treatment of brain tumors | Health Technology |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital invests in companies located in the United States with an enterprise value of USD 150 - 1000 million and revenue of USD 10 - 500 million. The firm targets companies operating in the fields of pharmaceuticals, biotech, drug development and discovery & healthcare services. It provides financing for buyout, recapitalization and growth stage capital requirements with an investment size of USD 10 - 250 million. The firm acquires majority, minority and controlling interest and makes co-investments. It also acts as a lead investor. | Finance |
Deinde Medical Corp.
Deinde Medical Corp. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Select your edition
All financial news and data tailored to specific country editions